FDA Inspection 1327446 — Bio Cell And Tissue Technologies, Inc.

Bio Cell And Tissue Technologies, Inc. — FEI 3007867618

The FDA completed an inspection of Bio Cell And Tissue Technologies, Inc. on Jul 7, 2026 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 7, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Salt Lake City, UT (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.